Health minister says private pathology companies should be able to absorb new costs but ‘it’s a matter of managing the trade’Private pathology companies are competitive enough to absorb the costs of reduced bulk-billing incentives,but some patients will still be hit with increased charges, the federal health minister, or Sussan Ley,has conceded.
The federal government announced in its budget update on Tuesday that it would reduce bulk-billing incentives for pathology services and diagnostic imaging.
Continue reading...
Source: theguardian.com